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1.  Introduction
1.1  Background 
The UNODC Laboratory and Scientific Section provides support to laboratories in 
introducing and implementing a quality management system through a number of 
initiatives,  including  the  provision  of  reference  samples  of  controlled  substances, 
laboratory manuals on recommended methods, training opportunities and the Inter-
national  Collaborative  Exercises  scheme  and  by  promoting  and  facilitating  the 
exchange of information, material and data [1].
The validation of analytical methods and the calibration of equipment are important 
aspects of quality assurance in the laboratory. This manual deals with both of these 
within the context of testing of illicit drugs in seized materials and biological speci-
mens. Further information on quality assurance is given in other UNODC manuals.
1.2  Purpose of the manual
The manual is intended to provide an introduction to the validation of analytical methods, 
and also the performance verification of laboratory equipment. It has been designed to 
provide practical guidance to national authorities and analysts in the implementation 
of method validation within their existing internal quality assurance programmes.
The procedures described in the manual represent a synthesis of the experience of 
scientists from several reputable laboratories around the world. Many professional 
organizations have also developed guidelines for method validation as a component 
of quality assurance and good laboratory practices, and these have been reviewed 
in preparing this manual. While there is diversity with respect to detail in method 
validation  protocols  according  to  their  context,  there  is  also  a  common  thread  of 
principle  underlying  all  systems.  In  general,  this  manual  attempts  to  promote  and 
harmonize national efforts by providing internationally acceptable guidelines. Impor-
tantly, it also focuses specifically on the issue of quality assurance and good laboratory 
practices in drug testing laboratories. It can also serve as an educational document 
and as a means of encouraging laboratories to consider quality assurance matters.2  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
1.3  Layout and terminology used in this manual
Subsequent parts are concerned with validation of analytical methods and calibra-
tion/performance verification of instrumentation and equipment. Method validation 
and verification aims to ensure that the results produced are fit for their intended 
purpose while calibration/performance verification of instrumentation and equipment 
is  concerned  with  ensuring  that  they  are  performing  correctly.  Validation  of  an 
analytical system, often referred to as system suitability testing, is concerned with 
checking the performance of the combination of method and equipment in day-to-day 
analytical procedures. 
The manual is divided into four major parts and a glossary of terms. 
PART  1  gives  an  overview  of  the  theory  and  practice  of  method  validation  and 
instrument calibration/performance verification. 
PART  2  is  intended  to  be  a  practical  guide  for  analysts.  It  contains  prescriptive 
recommendations on how to validate qualitative and quantitative methods, for both 
seized materials and biological specimens. These “quick start” recommendations are 
to assist in quickly and systematically identifying the validation requirements. 
PART 3 is intended to be a practical guide for calibration/performance verification 
of instrumentation and equipment subdivided into procedures for different instru-
mentation and equipment. 
PART 4 contains examples of standard operating procedures for method validation 
to assist the laboratory manager in preparing these documents for inclusion in the 
quality manual of the laboratory.
The ANNEX provides a glossary of selected terms which are particularly relevant 
to the topics of this manual. 
1.4  Use of the manual
The  suggested  approaches  to  method  validation  given  in  this  manual  have  been 
chosen on the basis of proven usefulness and value. However, while several skeleton 
models for method validation are provided which can, in part, be used directly, it 
is recommended that managers of laboratories should supervise the preparation of 
in-house validation procedures following the guidelines given. The final choice of 
the method validation system remains in the hands of the laboratory manager, who 
should also take responsibility for ensuring that staff comply with the prescribed 
procedures.Introduction 3
Attention is drawn to the importance of adequately trained staff where matters of 
quality assurance are concerned. Implementation of a written or formalized quality 
assurance programme, as required by an external accreditation system, can only be 
effectively carried out in cooperation with an informed and aware staff.
An important adjunct to the development of an internal quality assurance programme 
is participation in an external proficiency testing scheme and laboratories are encour-
aged  to  take  part  in  proficiency  testing  programmes  and  ring  tests  such  as  the 
International Collaborative Exercises (ICE) set up by UNODC within the Interna-
tional Quality Assurance Programme (IQAP). Within the context of validation of 
analytical methods, the importance of inter-laboratory tests is highlighted below (see 
part 2.8.)
The Laboratory and Scientific Section would welcome observations on the contents 
and usefulness of the present manual. Comments may be addressed to:
Laboratory and Scientific Section
United Nations Office on Drugs and Crime
Vienna International Centre, VIC
PO Box 500 
1400 Vienna
Austria
Fax: (+43-1) 26060-5967
Email: lab@unodc.org
Website: www.unodc.org5
2.    Validation and verification  
of analytical methods
2.1    Introduction: role of validation within quality 
assurance and good laboratory practices
Methods used in an analytical chemistry laboratory must be evaluated and tested to 
ensure that they produce valid results suitable for their intended purpose, i.e. they 
must be validated. Any laboratory which adopts UNODC recommended methods* 
should either revalidate them or verify them as appropriate to ensure that they work 
properly in its local environment. Verification involves fewer (see part 2.4 and 2.5 
below) experimental operations than validation. 
Any method newly introduced into a laboratory should also be documented and all 
analysts who will use it must receive adequate training and demonstrate their com-
petence in the method before commencing actual casework. Commercial methods 
also need revalidation, or at least verification. Manufacturers’ recommended proce-
dures should be followed as closely as possible. Otherwise, if significant changes 
are made, full validation is necessary. If a method is modified or applied to a new 
situation (e.g., different sample matrix), revalidation or verification would be required 
depending on the extent of the modification and the nature of new situation. Revali-
dation would be required, for example, when a method designed to work for urine 
is applied to blood; verification would be required when a chromatographic column 
of a different nature or dimension is used. No action is required where a modifica-
tion  is  only  small,  for  example  when  a  chromatographic  column  is  changed  for 
another of the same type. 
The validation or verification of a method follows a standardized set of experimental 
tests which produce data relating to accuracy, precision etc. The process by which 
this is done should be written down as a standard operating procedure (SOP). Once 
methods  have  been  validated  or  verified,  they  should  be  formally  authorized  for 
  * UNODC Laboratory and Scientific Section has published a series of manuals on recommended 
methods for testing major drugs of abuse, they are published under the symbols ST/NAR. The whole 
series or individual numbers are provided under request.6  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
routine use in the laboratory by the responsible person, for example the laboratory 
manager [2].
A “Method Authorization Form” or similar document specified in the quality manual 
records the details of the method and the data on which the evaluation of the method 
is based, including the following:
T   " itle of the method
A   " nalyte(s)
S   " ample matrix
S   " cientific basis of the method
V   " alidation study data (accuracy, precision, selectivity, range, LOD etc.)
N   " ame and position of the authorizing person
D   " ate
Note that the SOPs for validating or verifying a method, in common with all SOPs 
in  the  laboratory  quality  manual,  should  also  be  authorized  by  the  laboratory 
manager.
Once they have been established, it is essential that all SOPs are followed exactly. 
If variations are made, the variations must be documented. Any significant variations 
require that the method be revalidated for these new conditions. For all SOPs the 
last approved version should be used.
Laboratory documentation for a quality system is complex in nature, and therefore 
laboratories must have an appropriate document control procedure as recommended 
in the “Guidance for the Implementation of a Quality Management System in Drug 
Testing Laboratories” manual [3]. 
Systems proposed in the literature for the validation process may vary in several 
respects from these guidelines because validation is necessarily tied to the intended 
application. One of the benefits of these guidelines is that they have been tailored 
to the qualitative and quantitative analysis of controlled drug substances, either in 
seized materials or in biological specimens.
2.2  Evolution of a new method
Schematics for the evolution of a new method are provided in the ISO standards 
and other publications [4,5,6]. The following scheme is generally applicable.Validation and verification of analytical method 7
1.  Identify requirements
2.  Select candidate method (depends 
on: availability of equipment and 
facilities, staff expertise and require-
ments for staff training, regulatory 
requirements) 
3.  Develop method 
4.  Identify the type of method 
(specific requirements depend on 
whether it is a qualitative or quantita-
tive method and the techniques 
involved)
5.  Produce validation documentation 
6.  Write user instructions  
(Method SOP)
7.  Obtain management authorization
8.  Perform quality control to monitor 
compliance with acceptance criteria for 
end purpose (see step 1)
9.  Review method and propose changes 
10.  Obtain management authorization
Establishing end purpose
Literature search for existing method; or
Identification of a similar method; or 
Novel approach; or
Recommendation of colleagues; or
Recommendation of UNODC or other 
authoritative organization
Preliminary assessment to establish if it 
is capable of meeting the requirements
(See part 2.4) 
 
 
 
Writing up experimental/validation 
work (See part 2.6)
(See ST/NAR/25) 
(See part 2.1)
Using traceable standards, blanks, 
spiked samples, control charts, etc. and 
external proficiency testing programmes
Revalidating as appropriate  
Drafting revisions to SOP’s
Updating SOPs
  Step  Involves….
PRELIMINARY STEPS
METHOD VALIDATION
METHOD PERFORMANCE MONITORING AND REVIEW8  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
2.3  Preliminary steps
The central issue to be tackled before developing a new method is to establish the 
purpose for which the results will be used. This will then define acceptance criteria 
for the performance of the method and may well define or restrict the choice of 
techniques. To give an example, a method for the quantitative analysis of controlled 
drugs in seized materials will have certain minimum requirements with respect to 
accuracy  and  precision,  specificity,  etc.,  and  these  requirements  must  be  satisfied 
before the method can be accepted for routine use. As another example, a method 
for the analysis of low concentrations of drug metabolites in biological specimens 
may require the use of techniques with the highest sensitivity and selectivity, which 
may only be satisfied by gas chromatography or liquid chromatography in combina-
tion with mass spectrometry. 
It is important in terms of the laboratory’s human and financial resources to avoid 
unnecessary over-specification of the requirements for which the results will be used 
since  this  might  lead  to  prolonged  analysis  times,  increased  costs  and  redundant 
information. 
2.4  Method validation
Useful protocols for method validation in the literature have derived, amongst others, 
from the Current Good Manufacturing Practice, Code of Federal Regulations, Food 
and Drug Administration, National Drug Administration, the United States Pharma-
copoeia Convention, the American Public Health Association and the International 
Conference on Harmonization [2]. Additionally, the Scientific Working Group for 
the Analysis of Seized Drugs (SWGDRUG), ENFSI, IUPAC and Eurachem/CITAC 
have published detailed series of recommendations [5].
Methods can be classified in a number of ways [7], but in the present instance an 
important distinction should always be made between qualitative and quantitative 
methods. 
Qualitative methods for drugs testing require the following set of validation para-
meters to be determined:
S   " pecificity/selectivity
L   " imit of detection (LOD)
P   " recision (within the laboratory repeatability and/or within the laboratory 
reproducibility conditions)
S   " tabilityValidation and verification of analytical method 9
For those qualitative methods with a pre-defined threshold concentration for report-
ing results, the following three additional parameters should be determined:
L   " inearity
A   " ccuracy (bias) (under within laboratory repeatability and/or within labora-
tory reproducibility conditions) at the threshold concentration
P   " recision  (under  within  laboratory  repeatability  and/or  within  laboratory 
reproducibility conditions) at the threshold concentration
Quantitative  methods  for  drugs  testing  require  the  following  set  of  validation 
para  meters to be determined: 
S   " pecificity/selectivity
L   " imit of detection (LOD)
P   " recision  (under  within  laboratory  repeatability  and/or  within  laboratory 
reproducibility conditions)
L   " inearity and working range
A   " ccuracy (bias) (under within laboratory repeatability and within laboratory 
reproducibility conditions)
R   " ecovery
U   " ncertainty of measurement
S   " tability
Additional parameters to be determined which are desirable but not essential include 
lower limit of quantitation (LLOQ), ruggedness and robustness. For qualitative and 
quantitative methods that are to be used by more than one laboratory, each labora-
tory should verify the method, and the inter-laboratory precision and accuracy should 
be determined.
2.5  Method verification
When a laboratory is implementing a method which has already been validated, 
there is no need to revalidate the method fully, but its performance should be veri-
fied for the minimum set of parameters listed below. Usually, verification involves 
determining fewer parameters and making fewer measurements for each parameter 
than does validation. Results of verification may differ slightly from those obtained 
during  validation,  but  whether  they  are  acceptable  should  be  determined  by  the 
purpose for which the method will be used.10  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
Qualitative methods for drugs testing require the following set of verification para-
meters to be determined: 
S   " pecificity/selectivity if sample matrix differs from that used in the method 
development
L   " imit of detection (LOD)
P   " recision (under repeatability or reproducibility conditions)
For those qualitative methods with a pre-defined threshold concentration for report-
ing results, the following additional parameter should be determined:
A   " ccuracy (bias) at threshold concentration
P   " recision at threshold concentration
Accuracy and precision should be determined at the threshold concentration. 
Quantitative  methods  for  drugs  testing  require  the  following  set  of  verification 
parameters to be determined: 
S   " pecificity/selectivity and LOD if sample matrix differs from that used in 
method development
A   " ccuracy (bias) (under repeatability or reproducibility conditions)
P   " recision (under repeatability or reproducibility conditions)
2.6  Validation/verification parameters
Specificity (Selectivity)
This parameter is concerned with the extent to which other substances interfere with 
the identification and, where appropriate, quantification, of the analyte(s) of interest. 
It is a measure of the ability of the method to identify/quantify the analytes in the 
presence of other substances, either endogenous or exogenous, in a sample matrix 
under the stated conditions of the method.
Specificity is determined by adding materials which might be encountered in samples. 
For example, a specificity test of an immunological method for biological specimens 
may use potentially cross-reacting substances; a specificity test of a spot test could 
include potentially interfering substances which might inhibit or mask the colour 
reaction; a chromatographic method for the determination of concentrations of drugs 
of abuse in clinical samples should be free of interferences from the expected con-
comitantly  administered  therapeutic  drugs.  Specificity  is  concentration-dependent 
and should be determined at the low end of the calibration range. The validation Validation and verification of analytical method  11
should meet the purpose of the method and ensure that the effects of impurities, 
cross-reacting substances, etc., which may be present in the matrix are known.
Limit of detection (LOD)
This is the lowest analyte concentration that can be detected and identified with a 
given degree of certainty. The LOD is also defined as the lowest concentration that 
can be distinguished from the background noise with a certain degree of confidence. 
There  are  several  methods  of  estimating  the  LOD,  all  of  which  depend  on  the 
analysis of blank specimens and examination of the signal to noise ratio. A minimum 
requirement for signal to noise of 3 is widely accepted. The LOD is not a robust 
or rugged parameter and can be affected by minor changes in the analytical system 
(e.g. temperature, purity of reagents, matrix effects, instrumental conditions). It is 
therefore important that this parameter is always verified by laboratories adopting 
previously validated methods.
Precision (under Repeatability and/or Reproducibility conditions)
Precision  is  a  measure  of  the  closeness  of  the  analytical  results  obtained  from  a 
series of replicate measurements of the same measure under the conditions of the 
method. It reflects the random errors which occur in a method. 
Two commonly accepted sets of conditions under which precision is measured are 
repeatable and reproducible conditions. 
Repeatability conditions occur when the same analyst analyses samples on the same 
day with the same instrument (e.g. gas chromatograph) or materials (e.g. spot test 
reagents) in the same laboratory. Any variation from these conditions (e.g. different 
analysts, different days, different instruments, different laboratories) represent repro-
ducibility conditions. Precision is usually measured as the coefficient of variation 
or relative standard deviation of analytical results obtained from independently pre-
pared quality control standards. Precision is concentration dependent and should be 
measured at different concentrations within the working range, typically at the lower, 
mid and upper parts. Acceptable precision at the lower concentrations is 20%. At 
higher concentrations better precision would be expected. These acceptance criteria 
may be widened in some instances, for example the analysis of autopsy samples, 
where matrix effects may be significant.
Linearity and working range
Traditionally, methods are described as linear when there is a directly proportional 
relationship between the method response and concentration of the analyte in the 
matrix  over  the  range  of  analyte  concentrations  of  interest  (working  range). The 
working range is predefined by the purpose of the method and may reflect only a 12  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
part of the full linear range. Acceptance criteria usually involve a Goodness of Fit 
test. A high correlation coefficient (r) of 0.99 is often used as criterion of linearity. 
However, this is not sufficient to prove that a linear relationship exists, and a method 
with a coefficient of determination of less than 0.99 may still be fit for purpose. 
These parameters are not applicable to qualitative methods unless there is a threshold 
concentration for reporting results.
Accuracy (bias)
This is a measure of the difference between the expectation of the test result and 
the accepted reference value due to systematic method and laboratory error. It is 
usually expressed as a percentage. Accuracy and precision together determine the 
total error of the analysis. Accuracy is ideally determined using Certified Refer-
ence Materials (CRMs), if available, reference methods, collaborative studies or 
by   comparison with other methods [4].
In  practice,  CRMs  are  rarely  available  for  drugs  of  abuse.  For  drugs  of  abuse  in 
biological fluids there are the National Institute of Standards and Technology (NIST) 
CRMs but these do not cover a large menu of substances. As an alternative, reference 
standards  from  an  authoritative  organization  such  as  UNODC,  Drug  Enforcement 
Administration (DEA) or reputable commercial provider can be used. 
It is common to estimate accuracy by analysing samples spiked at three different 
concentrations (low, medium, high) covering the working range. The concentra-
tions of these standards should be different from those used for preparing the 
calibration curves and they should be prepared from a different stock standard 
solution.   Acceptability criteria for accuracy mirror those for precision.
Recovery
The recovery of an analyte in an assay is the detector response obtained from an 
amount  of  the  analyte  added  to  and  extracted  from  the  matrix,  compared  to  the 
detector response for the true concentration of the pure authentic standard (seized 
materials). It may also be understood as the percentage of the drug, metabolite, or 
internal standard originally in the specimen that reaches the end of the procedure. 
In the case of biological specimens, blanks of the biological matrix once the final 
extracts have been obtained may be spiked with the true concentration of the pure 
authentic standard and then analysed. Recovery experiments should be performed 
by  comparing  the  analytical  results  for  extracted  samples  at  three  concentrations 
(typically those corresponding to control samples used to evaluate a method’s preci-
sion and accuracy). Recovery of the analyte need not to be 100%, but the extent of 
recovery  (of  the  analyte  and  the  internal  standard)  should  be  consistent  (for  all 
concentrations tested), precise and reproducible (better than 20%)Validation and verification of analytical method  13
Uncertainty of measurement [8, 9, 10]
Testing laboratories should have and apply procedures for estimating uncertainty 
of measurement [1]. Considering uncertainty provides assurance that results and 
  conclusions from methods and analytical schemes are fit for purpose [11].
Metrologically, uncertainty is defined as a parameter associated with the result of meas-
urement that characterises the dispersion of the values that could reasonably be attributed 
to the measurand. (Measurand: Particular quantity subject to measurement.)
In  more  practical  terms,  uncertainty  can  be  defined  as  a  probability  or  level  of 
confidence. Any measurement we make will have some uncertainty associated with 
it and the uncertainty interval which we quote will be the range within which the 
true value lies at a certain level of confidence. Typically we use a 95% confidence 
interval [12]. 
Understanding of uncertainty is fundamental to the interpretation and reporting of 
results [11]. The laboratory shall at least attempt to identify all the components of 
uncertainty  and  make  a  reasonable  estimation,  and  shall  ensure  that  the  form  of 
reporting of the result does not give a wrong impression of the uncertainty.
Uncertainty of measurement comprises, in general, many components. The uncer-
tainty is calculated by estimating the errors associated with the various stages of 
the analysis, e.g. pre-analytical effects, homogenization, weighing, pipetting, injec-
tion, extraction, derivatisation, recovery, calibration curves. Validation data e.g. accu-
racy and precision under, repeatability/reproducibility conditions already account for 
many of these factors and should be used. 
Estimates of overall uncertainty at the 95% confidence level can be calculated using 
the following formula:
where u1, u2 etc are the individual component uncertainties. 
Individual component uncertainties that are less than 20% of the highest component 
uncertainty have little impact on the overall uncertainty and can be omitted from 
the calculation. 
Stability
The validation of the method should demonstrate the extent to which the analytes are 
stable during the whole analytical procedure, including storage before and after analy-
sis. In general, this is carried out by comparing freshly prepared standards of known 
concentration with similar standards retained for different periods of time and stored 
under various conditions. See reference [13] and further references therein.14  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
2.7  Method performance monitoring and review
After a method has been validated or verified, and implemented, there is a continu-
ing need within any quality assurance system to monitor that the method is still 
performing within its specifications. This process of monitoring involves on-going 
quality control of the method with blanks, controls and calibrators, and testing of 
the components of the system (this is sometimes referred to as system suitability 
testing) [14],  for  example,  column  performance  in  terms  of  resolution  and  peak 
shape, detector response and reagent specifications. Clear control limits (e.g. the 
acceptable  variability  in  detector  response)  should  be  specified  for  the  method, 
together  with  the  corrective  actions  which  should  follow  if  these  are  exceeded, 
including recalibration, reverification or revalidation of the method. 
2.8    Inter-laboratory collaborative exercises/
proficiency tests
These studies are essential to establish the reliability and compatibility of data that 
need to be shared. Collaborative exercises can be used as an integral part of method 
validation to estimate accuracy and precision under reproducibility conditions and to 
determine ruggedness. Some of these exercises require that the same method is used 
at each location. Collaborative exercises and proficiency testing schemes can be used 
to monitor and compare a laboratory’s performance against that of other laboratories 
producing  equivalent  data.  Several  external  quality  control  assurance  schemes  are 
available for controlled drugs analysis including the UNODC ICE. See also ISO/IEC 
Guide 43-1 and 43-2 for the accreditation of providers of PT schemes.
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In the repetitive full scan mode, the mass spectrum is used in conjunction with the 
retention time or relative retention time to identify and confirm drug(s) present. For 
identification purposes (relates to specificity and selectivity, accuracy) the retention 
time and mass spectrum of each drug in the sample are compared with those of an 
authentic standard analysed under identical conditions, usually in the same batch or 
within the same day. Alternatively, the mass spectrum can be compared with a library 
spectrum of the standard using a library search routine. The retention time of the 
suspected drug should agree closely with that of the standard if available (within a 
window of approximately ±2% of the retention time) and the mass spectrum should 
have a good visual match to that of the standard or should achieve a fit factor of 
900 or more in the library search (on a scale in which a perfect fit achieves a fit 
factor of 1,000). 
When used in the SIM/MRM mode, at least three ions/transitions are selected for 
each target analyte, typically including the base peak and molecular ion plus one 
other diagnostic ion. For identification purposes, the areas of peaks in the selected 
ion  chromatograms  at  the  analyte  retention  time  should  have  relative  intensities 
which match those of a standard analysed in the same batch under identical condi-
tions, with an allowable error of approximately ±20%. Similar criteria may be used 
for  computer-generated  mass  chromatograms  obtained  from  data  acquired  in  the 
repetitive full scan mode, if this mode provides adequate sensitivity, and a sufficient 
number (more than 12) of mass spectra across the chromatographic peak to permit 
peak areas to be determined with reasonable accuracy. If the mass spectrometer is 
operated in the chemical ionization mode, there may only be one ion present and 
identification of the drug will have to be on the basis of the retention time and fact 
that the ion is present.24  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
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o
n
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o
m
p
a
r
e
 
t
h
e
 
r
e
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u
l
t
s
 
o
b
t
a
i
n
e
d
 
f
o
r
 
e
a
c
h
 
s
p
i
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e
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b
l
a
n
k
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p
e
c
i
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t
 
e
a
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h
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c
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r
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n
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n
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c
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p
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c
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b
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e
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c
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e
t
t
e
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h
a
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a
t
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i
g
h
e
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o
n
c
e
n
t
r
a
t
i
o
n
.
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.
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.
2
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e
i
z
e
d
 
m
a
t
e
r
i
a
l
s
—
q
u
a
n
t
i
t
a
t
i
v
e
 
a
n
a
l
y
s
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c
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c
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c
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c
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M
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S
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c
i
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c
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e
l
e
c
t
i
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i
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u
a
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i
v
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a
n
a
l
y
s
i
s
A
s
 
f
o
r
 
q
u
a
l
i
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O
Q
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n
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y
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p
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e
c
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u
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c
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o
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t
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r
e
s
t
 
i
n
 
a
 
v
a
r
i
e
t
y
 
o
f
 
c
o
m
m
o
n
l
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o
c
c
u
r
r
i
n
g
 
m
a
t
r
i
c
e
s
 
a
t
 
a
 
s
e
r
i
e
s
 
o
f
 
d
i
l
u
-
t
i
o
n
s
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o
 
e
s
t
a
b
l
i
s
h
 
t
h
e
 
m
i
n
i
m
u
m
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
a
t
 
w
h
i
c
h
 
t
h
e
 
d
r
u
g
 
c
a
n
 
s
t
i
l
l
 
b
e
 
q
u
a
n
t
i
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e
d
 
w
i
t
h
 
c
o
n
fi
d
e
n
c
e
.
T
h
e
 
r
e
q
u
i
r
e
m
e
n
t
s
 
s
h
o
u
l
d
 
b
e
 
m
e
t
 
f
o
r
 
a
c
c
u
-
r
a
c
y
 
a
n
d
 
p
r
e
c
i
s
i
o
n
.
L
i
n
e
a
r
i
t
y
 
a
n
d
 
w
o
r
k
i
n
g
 
r
a
n
g
e
*
A
n
a
l
y
s
e
 
a
 
b
l
a
n
k
 
s
a
m
p
l
e
 
a
n
d
 
s
i
x
 
i
n
d
e
p
e
n
d
e
n
t
l
y
 
p
r
e
p
a
r
e
d
 
b
l
a
n
k
s
 
c
o
n
t
a
i
n
i
n
g
 
t
h
e
 
d
r
u
g
(
s
)
 
o
f
 
i
n
t
e
r
e
s
t
 
a
t
 
s
i
x
 
d
i
f
f
e
r
e
n
t
 
c
o
n
c
e
n
t
r
a
t
i
o
n
s
 
e
v
e
n
l
y
 
s
p
a
c
e
d
 
o
v
e
r
 
t
h
e
 
r
a
n
g
e
 
o
f
 
i
n
t
e
r
e
s
t
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r
k
i
n
g
 
r
a
n
g
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u
l
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b
e
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p
u
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c
c
u
r
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c
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r
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e
v
e
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i
g
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d
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m
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n
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l
o
w
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h
o
u
l
d
 
b
e
 
a
n
a
l
y
s
e
d
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n
 
r
e
p
l
i
c
a
t
e
 
o
n
 
t
h
r
e
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c
o
n
s
e
c
u
t
i
v
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d
a
y
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h
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u
m
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r
 
o
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r
e
p
l
i
c
a
t
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s
 
p
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r
 
c
o
n
c
e
n
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r
a
t
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l
e
v
e
l
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u
l
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b
e
 
a
t
 
l
e
a
s
t
 
t
h
r
e
e
.
 
T
h
e
 
d
i
f
f
e
r
e
n
c
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c
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b
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e
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p
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e
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c
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n
t
a
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l
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u
l
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l
l
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t
h
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o
f
 
t
h
e
 
e
x
p
e
c
t
e
d
 
v
a
l
u
e
 
a
t
 
t
h
e
 
l
o
w
e
r
 
c
o
n
c
e
n
t
r
a
-
t
i
o
n
s
 
a
n
d
 
w
i
t
h
i
n
 
±
1
5
%
 
a
t
 
h
i
g
h
e
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
s
.
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r
e
c
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s
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n
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m
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r
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t
h
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r
e
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u
l
t
s
 
o
b
t
a
i
n
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f
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e
a
c
h
 
s
p
i
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e
c
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c
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n
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n
g
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c
c
u
r
a
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a
n
d
 
e
x
p
r
e
s
s
 
t
h
e
 
v
a
r
i
a
t
i
o
n
 
i
n
 
t
e
r
m
s
 
o
f
 
t
h
e
 
R
S
D
 
f
o
r
 
e
a
c
h
 
c
o
n
c
e
n
t
r
a
t
i
o
n
.
T
h
e
 
R
S
D
 
s
h
o
u
l
d
 
b
e
 
b
e
t
t
e
r
 
t
h
a
n
 
2
0
%
 
a
t
 
l
o
w
e
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
a
n
d
 
b
e
t
t
e
r
 
t
h
a
n
 
1
5
%
 
a
t
 
h
i
g
h
e
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
.
R
e
c
o
v
e
r
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h
e
r
e
 
e
x
t
r
a
c
t
i
o
n
 
i
s
 
r
e
q
u
i
r
e
d
)
P
r
e
p
a
r
e
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a
m
p
l
e
s
 
o
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t
h
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t
a
r
g
e
t
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n
a
l
y
t
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a
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r
e
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i
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r
e
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c
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n
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r
a
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y
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c
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.
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e
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e
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p
l
i
c
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x
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r
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s
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f
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a
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m
p
l
e
.
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t
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a
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e
 
t
i
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n
a
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n
d
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r
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t
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n
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t
h
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h
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c
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l
c
u
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c
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p
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h
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s
R
e
c
o
v
e
r
y
 
%
 
=
 
[
A
1
/
A
2
]
 
x
 
1
0
0
F
o
r
 
t
h
e
 
e
x
t
r
a
c
t
e
d
 
s
a
m
p
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r
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R
e
c
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b
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c
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c
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p
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c
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c
i
b
l
e
 
a
n
d
 
p
r
o
v
i
d
e
s
 
a
d
e
q
u
a
t
e
 
L
L
O
Q
U
n
c
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m
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c
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l
c
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h
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v
e
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a
l
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u
n
c
e
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t
a
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n
t
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(
s
e
e
 
2
.
6
.
)
A
s
 
a
 
g
e
n
e
r
a
l
 
g
u
i
d
e
l
i
n
e
,
 
u
n
c
e
r
t
a
i
n
t
y
 
s
h
o
u
l
d
 
b
e
 
i
n
 
t
h
e
 
r
e
g
i
o
n
 
o
f
 
±
1
5
%
 
a
t
 
L
O
Q
;
 
±
1
0
%
 
m
i
d
-
r
a
n
g
e
 
o
r
 
h
i
g
h
e
r
.
(
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G
C
/
H
P
L
C
/
C
a
p
i
l
l
a
r
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e
l
e
c
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o
p
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i
s
S
p
e
c
i
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c
i
t
y
/
S
e
l
e
c
t
i
v
i
t
y
Α
s
 
f
o
r
 
q
u
a
l
i
t
a
t
i
v
e
 
a
n
a
l
y
s
i
s
Α
s
 
f
o
r
 
q
u
a
l
i
t
a
t
i
v
e
 
a
n
a
l
y
s
i
s
L
O
Q
A
n
a
l
y
s
e
,
 
o
n
c
e
 
e
a
c
h
,
 
1
0
 
s
a
m
p
l
e
 
b
l
a
n
k
s
 
e
x
t
r
a
c
t
e
d
 
f
r
o
m
 
a
 
t
y
p
i
c
a
l
 
d
r
u
g
 
m
a
t
r
i
x
 
e
a
c
h
 
c
o
n
t
a
i
n
i
n
g
 
t
h
e
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r
u
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c
o
n
c
e
n
t
r
a
t
i
o
n
s
 
n
e
a
r
 
t
o
 
t
h
e
 
m
i
n
i
m
u
m
 
l
e
v
e
l
 
(
c
l
o
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e
 
t
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L
O
D
)
 
a
t
 
w
h
i
c
h
 
a
 
s
i
g
n
a
l
 
i
s
 
j
u
s
t
 
o
b
s
e
r
v
e
d
 
t
o
 
i
n
d
i
c
a
t
e
 
i
t
s
 
p
r
e
s
e
n
c
e
.
 
E
x
p
r
e
s
s
 
t
h
e
 
L
O
Q
 
a
s
 
±
3
 
o
r
 
±
1
0
s
.
d
.
 
o
f
 
t
h
e
 
s
a
m
p
l
e
 
b
l
a
n
k
 
v
a
l
u
e
 
a
t
 
t
h
e
 
d
r
u
g
 
p
o
s
i
t
i
o
n
.
T
h
e
 
L
O
Q
 
s
h
o
u
l
d
 
b
e
 
fi
t
 
f
o
r
 
p
u
r
p
o
s
e
 
(
i
.
e
.
 
i
f
 
p
a
r
t
i
c
i
p
a
t
i
n
g
 
i
n
 
a
n
 
e
x
t
e
r
n
a
l
 
q
u
a
l
i
t
y
 
c
o
n
-
t
r
o
l
,
 
i
t
 
s
h
o
u
l
d
 
fi
t
 
q
u
a
l
i
t
y
 
o
b
j
e
c
t
i
v
e
s
 
a
p
p
l
i
e
d
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)
L
i
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i
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o
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k
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g
 
r
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n
g
e
*
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n
a
l
y
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b
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a
n
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s
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p
l
e
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i
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e
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t
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p
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e
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r
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b
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n
k
s
 
c
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t
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d
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o
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s
i
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n
c
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t
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o
n
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e
v
e
n
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s
p
a
c
e
d
 
c
o
v
e
r
i
n
g
 
t
h
e
 
r
a
n
g
e
 
o
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i
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e
r
e
s
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.
W
o
r
k
i
n
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r
a
n
g
e
 
s
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o
u
l
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b
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t
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o
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p
u
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o
s
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.
P
r
e
c
i
s
i
o
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u
n
d
e
r
 
r
e
p
e
a
t
a
b
i
l
i
t
y
 
a
n
d
 
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
 
c
o
n
d
i
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o
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s
A
n
a
l
y
s
e
 
1
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i
n
d
e
p
e
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d
e
n
t
l
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p
r
e
p
a
r
e
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b
l
a
n
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s
a
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p
l
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p
i
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c
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c
r
o
s
s
 
t
h
e
 
w
o
r
k
i
n
g
 
r
a
n
g
e
 
a
n
d
 
e
x
p
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e
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d
e
v
i
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e
a
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c
e
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o
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.
R
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f
o
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t
h
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o
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e
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o
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r
o
l
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u
s
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b
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o
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e
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b
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p
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b
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p
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r
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p
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c
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c
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In the repetitive full scan mode, the mass spectrum is used in conjunction with the 
retention time or relative retention time to identify and confirm drug(s) present. For 
identification purposes (relates to specificity and selectivity, accuracy) the retention 
time and mass spectrum of each drug in the sample are compared with those of an 
authentic standard analysed under identical conditions, usually in the same batch or 
within the same day. Alternatively, the mass spectrum can be compared with a library 
spectrum of the standard using a library search routine. The retention time of the 
suspected drug should agree closely with that of the standard if available (within a 
window of approximately ±2% of the retention time) and the mass spectrum should 
have a good visual match to that of the standard or should achieve a fit factor of 
900 or more in the library search (on a scale in which a perfect fit achieves a fit 
factor of 1,000). 
When used in the SIM/MRM mode, at least three ions/transitions are selected for 
each target analyte, typically including the base peak and molecular ion plus one 
other diagnostic ion. For identification purposes, the areas of peaks in the selected 
ion  chromatograms  at  the  analyte  retention  time  should  have  relative  intensities 
which match those of a standard analysed in the same batch under identical condi-
tions, with an allowable error of approximately ±20%. Similar criteria may be used 
for  computer-generated  mass  chromatograms  obtained  from  data  acquired  in  the 
repetitive full scan mode, if this mode provides adequate sensitivity, and a sufficient 
number  (more  than  twelve)  of  mass  spectra  across  the  chromatographic  peak  to 
permit peak areas to be determined with reasonable accuracy. If the mass spectro-
meter is operated in the chemical ionisation mode, there may only be one ion present 
and identification of the drug will have to be on the basis of the retention time and 
fact that the ion is present. For quantification purposes, one of the selected ions/
transitions is selected as the quantification ion/transition and the other ions/transi-
tions  serve  as  qualifier  ions  to  confirm  the  identity  of  the  suspected  drug.  The 
chromatograms  produced  for  the  quantification  ion/transition  are  used  in  method 
validation in a similar way to those obtained with other GC detectors such as the 
flame ionization detector.Validation and verification of analytical method  29
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o
m
 
a
t
 
l
e
a
s
t
 
fi
v
e
 
d
i
f
f
e
r
e
n
t
 
s
o
u
r
c
e
s
 
a
n
d
 
v
e
r
i
f
y
 
t
h
e
 
a
b
s
e
n
c
e
 
o
f
 
i
n
t
e
r
f
e
r
i
n
g
 
s
u
b
s
t
a
n
c
e
s
 
a
t
 
t
h
e
 
r
e
t
e
n
t
i
o
n
 
t
i
m
e
s
 
o
f
 
t
h
e
 
a
n
a
l
y
t
e
(
s
)
 
o
f
 
i
n
t
e
r
e
s
t
.
 
I
f
 
d
r
u
g
s
 
o
r
 
o
t
h
e
r
 
s
u
b
s
t
a
n
c
e
s
 
h
a
v
e
 
s
i
m
i
l
a
r
 
r
e
t
e
n
t
i
o
n
 
t
i
m
e
s
 
t
o
 
a
n
y
 
o
f
 
t
h
e
 
t
a
r
g
e
t
 
a
n
a
l
y
t
e
s
,
 
a
n
a
l
y
s
e
 
a
 
m
i
x
t
u
r
e
 
o
f
 
t
h
e
m
 
t
o
 
c
h
e
c
k
 
w
h
e
t
h
e
r
 
t
h
e
y
 
c
a
n
 
b
e
 
r
e
s
o
l
v
e
d
 
f
r
o
m
 
t
h
e
 
t
a
r
g
e
t
 
a
n
a
l
y
t
e
(
s
)
.
V
e
r
i
f
y
 
t
h
e
 
a
b
s
e
n
c
e
 
o
f
 
i
n
t
e
r
f
e
r
i
n
g
 
s
u
b
s
t
a
n
c
e
s
 
a
t
 
t
h
e
 
r
e
t
e
n
t
i
o
n
 
t
i
m
e
 
o
f
 
t
h
e
 
a
n
a
l
y
t
e
 
(
s
)
 
o
f
 
i
n
t
e
r
e
s
t
 
a
n
d
 
o
f
 
t
h
e
 
i
n
t
e
r
n
a
l
 
s
t
a
n
d
a
r
d
 
(
I
S
)
.
 
V
e
r
i
f
y
 
t
h
a
t
 
t
h
e
 
a
n
a
l
y
t
i
c
a
l
 
m
e
t
h
o
d
 
i
n
 
t
e
r
m
s
 
o
f
 
s
p
e
c
i
fi
c
i
t
y
 
a
n
d
 
s
e
l
e
c
t
i
v
i
t
y
 
i
s
 
fi
t
 
f
o
r
 
p
u
r
p
o
s
e
 
(
i
.
e
.
 
m
i
n
i
m
a
l
 
f
a
l
s
e
 
p
o
s
i
t
i
v
e
 
r
a
t
e
s
 
w
i
t
h
 
d
i
f
f
e
r
e
n
t
 
m
a
t
r
i
c
e
s
 
f
o
r
 
t
h
e
 
s
c
r
e
e
n
i
n
g
 
o
f
 
c
o
n
t
r
o
l
l
e
d
 
s
u
b
s
t
a
n
c
e
s
)
.
2
.
9
.
3
 
B
i
o
l
o
g
i
c
a
l
 
s
p
e
c
i
m
e
n
s
—
q
u
a
l
i
t
a
t
i
v
e
 
a
n
a
l
y
s
i
s
 
(
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e
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L
O
D
A
n
a
l
y
s
e
 
s
a
m
p
l
e
s
 
o
f
 
e
a
c
h
 
s
p
e
c
i
fi
c
 
d
r
u
g
 
i
n
 
t
h
e
 
c
l
a
s
s
(
e
s
)
 
o
f
 
i
n
t
e
r
e
s
t
 
i
n
 
a
 
v
a
r
i
e
t
y
 
o
f
 
c
o
m
m
o
n
l
y
 
o
c
c
u
r
r
i
n
g
 
m
a
t
r
i
c
e
s
 
a
t
 
a
 
s
e
r
i
e
s
 
o
f
 
d
i
l
u
t
i
o
n
s
 
t
o
 
e
s
t
a
b
l
i
s
h
 
t
h
e
 
m
i
n
i
m
u
m
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
a
t
 
w
h
i
c
h
 
t
h
e
 
d
r
u
g
 
c
a
n
 
s
t
i
l
l
 
b
e
 
d
e
t
e
c
t
e
d
 
w
i
t
h
 
c
o
n
fi
d
e
n
c
e
 
(
s
i
g
n
a
l
 
t
o
 
n
o
i
s
e
 
r
a
t
i
o
 
o
f
 
a
t
 
l
e
a
s
t
 
3
:
1
)
.
L
O
D
 
s
h
o
u
l
d
 
b
e
 
s
u
f
fi
c
i
e
n
t
l
y
 
l
o
w
 
f
o
r
 
t
h
e
 
p
u
r
p
o
s
e
 
o
f
 
t
h
e
 
a
n
a
l
y
s
i
s
.
 
T
y
p
i
c
a
l
l
y
,
 
a
 
t
e
s
t
 
m
i
g
h
t
 
b
e
 
r
e
q
u
i
r
e
d
 
t
o
 
d
e
t
e
c
t
 
t
h
e
 
a
n
a
l
y
t
e
 
a
t
 
t
h
e
 
m
i
n
i
m
u
m
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
l
i
k
e
l
y
 
t
o
 
b
e
 
f
o
u
n
d
 
i
n
 
s
p
e
c
i
m
e
n
s
 
e
n
c
o
u
n
t
e
r
e
d
 
b
y
 
t
h
e
 
l
a
b
o
r
a
t
o
r
y
.
P
r
e
c
i
s
i
o
n
 
u
n
d
e
r
 
r
e
p
e
a
t
a
b
i
l
i
t
y
 
a
n
d
 
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
 
c
o
n
d
i
t
i
o
n
s
A
n
a
l
y
s
e
 
a
t
 
l
e
a
s
t
 
1
0
 
r
e
p
l
i
c
a
t
e
 
s
a
m
p
l
e
s
 
o
f
 
k
n
o
w
n
 
c
o
m
p
o
s
i
t
i
o
n
 
a
t
 
a
n
 
a
m
o
u
n
t
 
b
e
t
w
e
e
n
 
1
.
2
5
 
x
 
L
O
D
 
a
n
d
 
2
 
x
 
L
O
D
.
D
e
t
e
r
m
i
n
e
 
t
h
e
 
v
a
r
i
a
t
i
o
n
 
(
R
S
D
)
 
i
n
 
r
e
t
e
n
t
i
o
n
 
t
i
m
e
s
 
r
e
l
a
t
i
v
e
 
t
o
 
t
h
e
 
i
n
t
e
r
n
a
l
 
s
t
a
n
d
a
r
d
.
N
o
 
m
o
r
e
 
t
h
a
n
 
o
n
e
 
s
a
m
p
l
e
 
i
n
 
fi
v
e
 
(
2
0
%
)
 
s
h
o
u
l
d
 
g
i
v
e
 
a
 
f
a
l
s
e
 
n
e
g
a
t
i
v
e
 
r
e
s
u
l
t
.
R
S
D
 
s
h
o
u
l
d
 
b
e
 
b
e
t
t
e
r
 
t
h
a
n
 
±
2
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P
a
r
a
m
e
t
e
r
V
a
l
i
d
a
t
i
o
n
 
r
e
q
u
i
r
e
m
e
n
t
s
A
c
c
e
p
t
a
n
c
e
 
c
r
i
t
e
r
i
a
(
c
)
 
I
m
m
u
n
o
a
s
s
a
y
 
(
s
e
m
i
-
q
u
a
n
t
i
t
a
t
i
v
e
)
S
p
e
c
i
fi
c
i
t
y
/
S
e
l
e
c
t
i
v
i
t
y
I
m
m
u
n
o
a
s
s
a
y
s
 
f
r
o
m
 
c
o
m
m
e
r
c
i
a
l
 
s
o
u
r
c
e
s
 
a
l
r
e
a
d
y
 
p
r
o
v
i
d
e
 
i
n
f
o
r
m
a
t
i
o
n
 
a
b
o
u
t
 
t
h
e
 
s
p
e
c
i
fi
c
i
t
y
 
a
n
d
 
t
h
e
 
s
e
l
e
c
t
i
v
i
t
y
 
o
f
 
t
h
e
 
m
e
t
h
o
d
.
 
T
h
i
s
 
i
n
f
o
r
m
a
t
i
o
n
 
d
o
e
s
 
n
o
t
 
n
e
e
d
 
t
o
 
b
e
 
v
e
r
i
fi
e
d
 
i
f
 
t
h
e
 
i
m
m
u
n
o
a
s
s
a
y
 
i
s
 
u
s
e
d
 
o
n
l
y
 
f
o
r
 
i
t
s
 
i
n
t
e
n
d
e
d
 
p
u
r
p
o
s
e
.
T
h
e
 
u
t
i
l
i
z
a
t
i
o
n
 
o
f
 
t
h
e
 
i
m
m
u
n
o
a
s
s
a
y
 
w
i
t
h
 
b
i
o
l
o
g
i
c
a
l
 
m
a
t
r
i
c
e
s
 
o
t
h
e
r
 
t
h
a
n
 
t
h
o
s
e
 
a
l
r
e
a
d
y
 
v
a
l
i
d
a
t
e
d
 
b
y
 
t
h
e
 
m
a
n
u
f
a
c
t
u
r
e
r
 
e
.
g
.
 
b
l
o
o
d
 
r
a
t
h
e
r
 
t
h
a
n
 
u
r
i
n
e
,
 
w
i
l
l
 
r
e
q
u
i
r
e
 
i
t
s
 
v
a
l
i
d
a
t
i
o
n
,
 
e
s
p
e
c
i
a
l
l
y
 
f
o
r
 
m
a
t
r
i
x
 
e
f
f
e
c
t
s
.
T
o
 
v
a
l
i
d
a
t
e
 
a
n
 
i
m
m
u
n
o
a
s
s
a
y
,
 
a
n
a
l
y
s
e
 
u
n
d
e
r
 
t
h
e
 
s
p
e
c
i
fi
e
d
 
t
e
s
t
 
c
o
n
d
i
t
i
o
n
s
:
S
a
m
p
l
e
s
 
s
p
i
k
e
d
 
w
i
t
h
 
c
o
n
t
r
o
l
l
e
d
 
d
r
u
g
s
 
a
n
d
/
o
r
 
m
e
t
a
b
o
l
i
t
e
s
 
i
n
 
t
h
e
 
g
r
o
u
p
(
s
)
 
o
f
 
i
n
t
e
r
e
s
t
;
 
"
E
x
a
m
p
l
e
s
 
o
f
 
c
o
n
t
r
o
l
l
e
d
 
d
r
u
g
s
 
f
r
o
m
 
o
t
h
e
r
 
c
l
a
s
s
e
s
;
 
"
S
u
b
s
t
a
n
c
e
s
 
c
o
m
m
o
n
l
y
 
f
o
u
n
d
 
i
n
 
t
h
e
 
m
a
t
r
i
x
 
i
n
 
w
h
i
c
h
 
t
h
e
 
d
r
u
g
 
i
s
 
a
n
a
l
y
z
e
d
;
 
"
A
t
 
l
e
a
s
t
 
2
0
 
s
p
e
c
i
m
e
n
s
 
k
n
o
w
n
 
t
o
 
b
e
 
p
o
s
i
t
i
v
e
;
 
"
A
t
 
l
e
a
s
t
 
2
0
 
s
p
e
c
i
m
e
n
s
 
k
n
o
w
n
 
t
o
 
b
e
 
n
e
g
a
t
i
v
e
 
f
r
o
m
 
d
i
f
f
e
r
e
n
t
 
i
n
d
i
v
i
d
u
a
l
s
 
"
T
h
e
r
e
 
s
h
o
u
l
d
 
b
e
 
n
o
 
s
i
g
n
i
fi
c
a
n
t
 
c
r
o
s
s
-
r
e
a
c
t
i
v
i
t
y
 
w
i
t
h
 
o
t
h
e
r
 
d
r
u
g
s
 
o
r
 
s
u
b
s
t
a
n
c
e
s
.
 
L
O
D
I
m
m
u
n
o
a
s
s
a
y
s
 
f
r
o
m
 
c
o
m
m
e
r
c
i
a
l
 
s
o
u
r
c
e
s
 
u
s
u
a
l
l
y
 
p
r
o
v
i
d
e
 
i
n
f
o
r
m
a
t
i
o
n
 
a
b
o
u
t
 
t
h
e
 
L
O
D
.
I
f
 
v
a
l
i
d
a
t
i
o
n
 
i
s
 
n
e
c
e
s
s
a
r
y
,
 
e
.
g
.
 
t
o
 
a
n
a
l
y
s
e
 
f
o
r
 
a
 
n
e
w
 
a
m
p
h
e
t
a
m
i
n
e
 
d
e
r
i
v
a
t
i
v
e
 
i
n
 
t
h
e
 
s
a
m
e
 
m
a
t
r
i
x
 
o
r
 
t
o
 
t
e
s
t
 
f
o
r
 
d
r
u
g
s
 
i
n
 
a
 
d
i
f
f
e
r
e
n
t
 
m
a
t
r
i
x
,
 
a
n
a
l
y
s
e
 
1
0
 
i
n
d
e
p
e
n
d
e
n
t
 
r
a
n
d
o
m
i
s
e
d
 
r
e
p
l
i
c
a
t
e
s
 
o
f
 
b
l
a
n
k
 
s
p
e
c
i
m
e
n
s
 
s
p
i
k
e
d
 
w
i
t
h
 
t
h
e
 
d
r
u
g
 
o
f
 
i
n
t
e
r
e
s
t
 
a
t
 
a
 
r
a
n
g
e
 
o
f
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
l
e
v
e
l
s
 
t
o
 
d
e
t
e
r
m
i
n
e
 
t
h
e
 
m
i
n
i
m
u
m
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
w
h
i
c
h
 
c
a
n
 
b
e
 
r
e
l
i
a
b
l
y
 
d
e
t
e
c
t
e
d
S
h
o
u
l
d
 
b
e
 
s
u
b
s
t
a
n
t
i
a
l
l
y
 
l
o
w
e
r
 
t
h
a
n
 
t
h
e
 
c
u
t
-
o
f
f
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
s
o
 
t
h
a
t
 
b
o
t
h
 
n
e
g
a
t
i
v
e
 
a
n
d
 
p
o
s
i
t
i
v
e
 
s
a
m
p
l
e
s
 
c
a
n
 
b
e
 
r
e
l
i
a
b
l
y
 
c
l
a
s
s
i
fi
e
d
.
2
.
9
.
3
 
B
i
o
l
o
g
i
c
a
l
 
s
p
e
c
i
m
e
n
s
—
q
u
a
l
i
t
a
t
i
v
e
 
a
n
a
l
y
s
i
s
 
(
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P
r
e
c
i
s
i
o
n
 
u
n
d
e
r
 
r
e
p
e
a
t
a
b
i
l
i
t
y
 
a
n
d
 
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
 
c
o
n
d
i
t
i
o
n
s
.
F
o
r
 
m
o
s
t
 
i
m
m
u
n
o
a
s
s
a
y
s
 
t
h
e
 
d
e
c
i
s
i
o
n
 
t
o
 
r
e
p
o
r
t
 
t
h
e
 
p
r
e
s
e
n
c
e
 
o
r
 
a
b
s
e
n
c
e
 
o
f
 
a
 
g
i
v
e
n
 
s
u
b
s
t
a
n
c
e
 
s
h
o
u
l
d
 
n
o
t
 
b
e
 
b
a
s
e
d
 
o
n
 
L
O
D
 
b
u
t
 
o
n
 
a
 
c
u
t
-
o
f
f
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
a
p
p
l
i
e
d
 
a
s
 
t
h
e
 
c
r
i
t
e
r
i
o
n
 
f
o
r
 
a
 
p
o
s
i
t
i
v
e
.
T
h
e
 
p
e
r
f
o
r
m
a
n
c
e
 
o
f
 
a
n
 
i
m
m
u
n
o
a
s
s
a
y
 
w
i
t
h
 
a
 
d
e
fi
n
e
d
 
t
h
r
e
s
h
o
l
d
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
c
u
t
-
o
f
f
)
 
s
h
o
u
l
d
 
b
e
 
v
e
r
i
fi
e
d
 
b
y
 
r
u
n
n
i
n
g
 
c
o
n
t
r
o
l
 
s
a
m
p
l
e
s
 
i
n
 
a
n
a
l
y
t
i
c
a
l
 
b
a
t
c
h
e
s
 
s
p
i
k
e
d
 
w
i
t
h
 
c
o
n
c
e
n
t
r
a
t
i
o
n
s
 
c
l
o
s
e
 
t
o
 
t
h
e
 
c
u
t
-
o
f
f
 
(
±
2
5
%
 
o
f
 
t
h
e
 
c
u
t
-
o
f
f
 
c
o
n
c
e
n
t
r
a
t
i
o
n
)
.
 
I
n
t
r
a
-
d
a
y
 
p
r
e
c
i
s
i
o
n
 
(
r
e
p
e
a
t
a
b
i
l
i
t
y
)
 
c
a
n
 
b
e
 
d
e
t
e
r
m
i
n
e
d
 
b
y
 
r
u
n
n
i
n
g
 
c
o
n
t
r
o
l
 
s
a
m
p
l
e
s
 
w
h
i
c
h
 
h
a
v
e
 
b
e
e
n
 
s
p
i
k
e
d
 
w
i
t
h
 
a
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
o
f
 
a
n
a
l
y
t
e
 
w
h
i
c
h
 
i
s
 
a
b
o
u
t
 
2
5
%
 
h
i
g
h
e
r
 
t
h
a
n
 
t
h
e
 
t
h
r
e
s
h
o
l
d
 
v
a
l
u
e
.
 
T
h
e
 
R
S
D
 
o
f
 
t
h
e
s
e
 
d
a
t
a
 
s
h
o
u
l
d
 
b
e
 
c
a
l
c
u
l
a
t
e
d
.
 
I
n
t
e
r
-
d
a
y
 
p
r
e
c
i
s
i
o
n
 
(
i
n
t
e
r
m
e
d
i
a
t
e
 
p
r
e
c
i
s
i
o
n
)
 
c
a
n
 
b
e
 
o
b
t
a
i
n
e
d
 
b
y
 
a
c
c
u
m
u
l
a
t
i
n
g
 
d
a
t
a
 
o
f
 
c
o
n
t
r
o
l
 
s
a
m
p
l
e
s
,
 
s
p
i
k
e
d
 
w
i
t
h
 
a
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
o
f
 
a
n
a
l
y
t
e
 
w
h
i
c
h
 
i
s
 
a
b
o
u
t
 
2
5
%
 
h
i
g
h
e
r
 
t
h
a
n
 
t
h
e
 
t
h
r
e
s
h
o
l
d
 
v
a
l
u
e
,
 
w
h
i
c
h
 
s
h
o
u
l
d
 
b
e
 
r
u
n
 
r
o
u
t
i
n
e
l
y
 
i
n
 
e
v
e
r
y
 
a
n
a
l
y
t
i
c
a
l
 
b
a
t
c
h
.
 
T
h
e
 
R
S
D
 
o
f
 
t
h
e
s
e
 
d
a
t
a
 
s
h
o
u
l
d
 
b
e
 
c
a
l
c
u
l
a
t
e
d
.
F
o
r
 
r
e
p
e
a
t
a
b
i
l
i
t
y
 
(
i
n
t
r
a
-
d
a
y
 
p
r
e
c
i
s
i
o
n
)
 
a
n
d
 
i
n
t
e
r
m
e
d
i
a
t
e
 
(
i
n
t
e
r
-
d
a
y
 
p
r
e
c
i
s
i
o
n
)
 
t
h
e
 
R
S
D
 
v
a
l
l
u
e
s
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In the repetitive full scan mode, the mass spectrum is used in conjunction with the 
retention time or relative retention time to identify and confirm drug(s) present. For 
identification purposes (relates to specificity and selectivity, accuracy) the retention 
time and mass spectrum of each drug in the sample are compared with those of an 
authentic standard analysed under identical conditions, usually in the same batch or 
within the same day. Alternatively, the mass spectrum can be compared with a library 
spectrum of the standard using a library search routine. The retention time of the 
suspected drug should agree closely with that of the standard if available (within a 
window of approximately ±2% of the retention time) and the mass spectrum should 
have a good visual match to that of the standard or should achieve a fit factor of 
900 or more in the library search (on a scale in which a perfect fit achieves a fit 
factor of 1,000). 
When used in the SIM/MRM mode, at least three ions/transitions are selected for 
each target analyte, typically including the base peak and molecular ion plus one 
other diagnostic ion. For identification purposes, the areas of peaks in the selected 
ion  chromatograms  at  the  analyte  retention  time  should  have  relative  intensities 
which match those of a standard analysed in the same batch under identical condi-
tions, with an allowable error of approximately ±20%.
Similar criteria may be used for computer-generated mass chromatograms obtained 
from data acquired in the repetitive full scan mode, if this mode provides adequate 
sensitivity, and a sufficient number (more than twelve) of mass spectra across the 
chromatographic peak to permit peak areas to be determined with reasonable accu-
racy. If the mass spectrometer is operated in the chemical ionization mode, there 
may only be one ion present and identification of the drug will have to be on the 
basis of the retention time and fact that the ion is present.Validation and verification of analytical method  35
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In the repetitive full scan mode, the mass spectrum is used in conjunction with the 
retention time or relative retention time to identify and confirm drug(s) present. For 
identification purposes (relates to specificity and selectivity, accuracy) the retention 
time and mass spectrum of each drug in the sample are compared with those of an 
authentic standard analysed under identical conditions, usually in the same batch or 
within the same day. Alternatively, the mass spectrum can be compared with a library 
spectrum of the standard using a library search routine. The retention time of the 
suspected drug should agree closely with that of the standard if available (within a 
window of approximately ±2% of the retention time) and the mass spectrum should 
have a good visual match to that of the standard or should achieve a fit factor of 
900 or more in the library search (on a scale in which a perfect fit achieves a fit 
factor of 1,000). 
When used in the SIM/MRM mode, at least three ions/transitions are selected for 
each target analyte, typically including the base peak and molecular ion plus one 
other diagnostic ion. For identification purposes, the areas of peaks in the selected 
ion  chromatograms  at  the  analyte  retention  time  should  have  relative  intensities 
which match those of a standard analysed in the same batch under identical condi-
tions, with an allowable error of approximately ±20%. Similar criteria may be used 
for  computer-generated  mass  chromatograms  obtained  from  data  acquired  in  the 
repetitive full scan mode, if this mode provides adequate sensitivity, and a sufficient 
number  (more  than  twelve)  of  mass  spectra  across  the  chromatographic  peak  to 
permit peak areas to be determined with reasonable accuracy. If the mass spectro-
meter is operated in the chemical ionization mode, there may only be one ion present 
and identification of the drug will have to be on the basis of the retention time and 
fact that the ion is present. 
For quantification purposes, one of the selected ions/transitions is selected as the 
quantification ion/transition and the other ions/transitions serve as qualifier ions to 
confirm  the  identity  of  the  suspected  drug. The  chromatograms  produced  for  the 
quantification ion/transition are used in method validation in a similar way to those 
obtained with other GC detectors such as the flame ionization detector.39
3.    Calibration/performance verification 
of instruments and equipment
3.1  Introduction
The performance of laboratory instruments and equipment may change with time, 
either  in  the  short  term  owing  to  fluctuations  in  the  environment  or,  in  the  long 
term, owing to ageing of the mechanical, optical or electronic components. Slow 
changes may not be obvious and can lead to errors in the results obtained. In addi-
tion, performance can be affected by repairs or replacement of modules or compo-
nents. It is also possible that new equipment has not been tested or checked against 
specifications before delivery. 
Within a laboratory which maintains a comprehensive quality system, all aspects of 
analytical work are controlled, and these potential instrumental errors are controlled 
by carrying out regular preventative maintenance and calibration procedures. The 
way  in  which  the  performance  of  instruments  and  equipment  is  to  be  monitored 
(the terms performance verification [4] or performance qualification [16] are used 
to denote this), and the frequency of the calibration checks (calibration interval), 
should be stipulated in Standard Operating Procedures (SOPs).
Performance verification should be based on tests which are not specific to particular 
methods and which use traceable calibrators and standards, thus allowing equipment 
to  be  compared  between  laboratories.  Performance  verification  is  not  specifically 
related to either screening or confirmatory methods. The calibration of instruments 
and equipment (e.g., wavelength calibration of an IR spectrometer, mass calibration 
of a GCMS) is independent of the type of sample. 
Two conceptual approaches to the calibration process exist:
T   " he traditional approach, where all instruments and equipment are calibrated 
and
T   " he approach where calibration applies only to instruments providing physical 
measurements, and where the result is a direct measurement of a traceable 
physical parameter. For example, balances, spectrometers, thermometers, cen-
trifuges  and  chronometers  may  be  calibrated  because  there  are  traceable 40  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
standards to determine the uncertainty of the measurements. In all other cases, 
only performance verification of the equipment/instruments can be done in 
the laboratory; without an estimation of uncertainty there is no calibration. 
It is up to the laboratory to decide which approach to follow.
3.2  Metrological requirements
The  laboratory  should  be  furnished  with  all  items  of  sampling  measurement  and 
test equipment devices for the correct performance of tests and calibrations. Prior 
to  use,  equipment  should  also  be  checked  and  calibrated  that  meets  laboratories’ 
requirements and complies with standard specifications. The laboratory should have 
an established programme and procedure of the calibration of its equipment [17].
Some instrument and equipment suppliers can provide calibration certificates as part 
of a routine maintenance contract. Current requirements of quality assurance and good 
laboratory practice are that records should be kept in the log-book of each instrument 
of all calibration procedures and checks, and of remedial action if a check indicates 
that an instrument is out of calibration, as summarized in the table below.
Checklist of information to be kept in the instrument maintenance 
log-book [4]
Name of the equipment
Name of the manufacturer, model and/or type
Serial number
Date of receipt of equipment in laboratory
Condition when received (new, used)
Details of checks made for compliance with relevant calibration or test 
standard specification
Date equipment was placed in service by the laboratory
Current location in the laboratory, if appropriate
Copy of the manufacturer’s operating instruction(s)
Performance criteria defined according to the requirements of the type of 
analyses to be carried out with this instrument
Details of maintenance carried out and records of the subsequent 
performance check
History of any damage, malfunction, modification or repair and records 
of the subsequent performance check
Frequency of checking the performance criteriaCalibration/performance verification of instruments and equipment  41
3.3    Procedures for calibration/performance 
verification of instruments and equipment
Calibration procedures for apparatus used in analytical chemistry are often supplied 
by  the  manufacturer,  together  with  information  on  routine  maintenance  and  the 
frequency at which these are carried out. The following paragraphs provide guide-
lines for writing and performing standard calibration procedures for commonly used 
instruments and equipment [13,15].
Autopipettes
Apart from calibration, routine maintenance requires regular checks on the syringe 
assembly, by disassembly and cleaning if necessary.
Parameter to be calibrated: volume delivered.
Method: for fixed-volume pipettes, distilled water is pipetted into a weighed container 
to check the volume actually delivered. Increased accuracy is obtained if the balance 
used to check the weight has a weighing chamber saturated with water vapour, often 
provided  as  an  accessory  on  modern  electronic  balances. Variable  volume  pipettes 
should be calibrated at least at four settings: the maximum volume setting, the mini-
mum volume setting designated by the officer in charge of the autopipette, and two 
or more intermediate volume settings, one of which should be below the mid-point 
of the range. A variable volume pipette used to dispense a fixed volume only can be 
calibrated  at  that  fixed  volume. Adjustments  to  the  volume  setting  mechanism,  if 
required, should be made according to the manufacturer’s instructions.
Calibration  interval:  the  rate  of  drift  from  calibration  should  be  determined  by 
  carrying out frequent calibration checks (daily). The calibration interval can then be 
lengthened  to  a  time  period  (normally  three  month  intervals)  appropriate  for  the 
conditions of the laboratory.
Melting point apparatus
Parameter to be calibrated: Accuracy of thermometer.
Method: The melting points of reference substances are measured at least twice.
Calibration interval: Half-yearly. 
pH meters
Parameter to be calibrated: pH accuracy and linearity.
Method: Commercially-prepared buffers or standard buffers (as specified in a phar-
macopoeia) are used according to the manufacturer’s instructions.
Calibration interval: Daily when in use.42  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
Ovens and heating blocks
Parameter to be calibrated: Temperature.
Method:  Checked  with  a  portable  reference  pyrometer  or  precision  thermometer, 
which should be placed as close as possible to the oven temperature sensor.
Calibration interval: Annually, and after repairs which may affect the performance 
of the oven/heating block.
Water baths
Parameter to be calibrated: Temperature.
Method: Precision/reference thermometer.
Calibration interval: Quarterly, when water bath thermometer has been replaced, or 
when the water bath has not been used for a prolonged period (weeks or months).
Balances
Before use, balances should be checked to ensure that they are clean and level on 
the bench. An annual service visit by a qualified maintenance engineer is essential. 
At a minimum, balances used for critical weighing (i.e. where the combined uncer-
tainties in the weighing process contribute significantly, say 10 % of the total error, 
to  the  accuracy  of  the  overall  result)  should  have  calibration  certificates.  These 
certificates should be issued either by an external accredited body or by properly 
trained laboratory personnel. The certificates should be renewed yearly.
Parameter to be calibrated: Accuracy.
Method: Reference weights are used according to the manufacturer’s recommendations. 
The user may decide as per fitness for purpose, to use weight standards prepared to 
stricter standards than those stated by manufacturer. A typical sequence is to check and 
set the zero point with nothing on the balance pan then to place a reference weight on 
the  pan  and  adjust  the  reading  to  give  the  correct  value.  Please  note  that  reference 
weights must be handled with great care using forceps with smooth tips, as serrated tips 
can result in damage to the weights. Modern electronic balances frequently have internal 
calibration weights and the calibration check is carried out automatically, according to 
a pre-set sequence created by the manufacturer or, on demand, by the user.
Calibration interval: Microbalances used for preparing reference standards should 
be checked daily or each time they are used, if they are not used every day. Top pan 
balances for reagents and less critical weights can be checked less frequently, for 
example weekly or monthly, but it is important to monitor the rate of drift in the 
first instance to determine the correct calibration interval. Calibration checks should 
also be carried out whenever the balance has been moved.Calibration/performance verification of instruments and equipment  43
Refrigerators and freezers
Parameter to be calibrated: Temperature.
Method:  Precision  thermometer.  The  temperature  should  be  maintained  within  a 
maximum of ±5 degrees of the required temperature.
Calibration interval: continuously.
Instruments for immunological methods
Many different immunological methods are available and most depend on a direct 
comparison with calibration standards included in each batch of test samples. Par-
ticularly important is the cut-off concentration of analyte used, and the analyst should 
be aware of which cut-off concentrations have been adopted by the manufacturer 
of  the  immunoassay  kits  in  use.  Calibration  procedures  to  be  followed  are  those 
specified by the manufacturer.
Notable  exceptions  to  this  general  procedure  are  the  single-test  immunoassay 
kits (sometimes referred to as “dip-stick” tests), which may have in-built con-
trols, but not always. In principle, these produce a “positive” or “negative” result 
if the concentration of the target analyte is above or below the cut-off concen-
tration. It should be noted that there is often some degree of interpretation on 
the part of the operator and that, as always, a trained and experienced operator 
will produce more accurate and consistent results than one who has little experi-
ence of the method.
UV-Visible spectrometers
Parameter  to  be  calibrated:  Wavelength  accuracy  and  repeatability,  photometric 
accuracy.
Method: UV absorption wavelengths are checked with holmium and didymium filters, 
which should be supplied by the manufacturer. The wavelength accuracy and repeat-
ability are checked over the entire UV-visible range. At least two spectra are run. 
The maximum deviation is ±1.0 nm.
Calibration interval: Annually.
Infrared spectrometers:
The procedures below are for stand-alone spectrometers. Combined instruments such 
as GC-FTIR should be calibrated according to the manufacturer’s instructions.
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Method: The total range of the instrument is scanned using a polystyrene film. The 
absorption  peak  at  3095  nm  should  be  resolved  from  that  at  3080  nm  and  the 
absorption at 3020 nm should be resolved from that at 3015 nm.
Calibration interval: Quarterly.
Parameter to be calibrated: Wavelength accuracy.
Method: A polystyrene film is scanned and the accuracy of the peaks at 2852, 1602 
and 1028 nm is checked [18]. The accuracy should be within ±3-5 nm in the range 
4000-2000 nm and ± 1.5-2.5 nm in the range below 2000 nm.
Calibration interval: Quarterly.
Gas chromatographs
Routine maintenance operations used include checks on the septum, injector liner, 
gas pressures and inlet filters (e.g. oxygen scrubber, moisture trap and charcoal trap), 
baseline signal level and background noise. Depending on the degree of usage of 
the instrument, it is sensible to have a routine maintenance programme involving 
weekly  change  of  the  septum  and  injector  liner  (more  often  if  large  numbers  of 
samples are analysed).
Parameter to be calibrated: Oven temperature.
Method:  Checked  with  a  portable  reference  pyrometer  or  precision  thermometer, 
which should be placed as close as possible to the oven temperature sensor.
Calibration interval: Annually.
Parameters to be verified: Column performance (efficiency, resolution, peak shape, 
retention times).
Method: A set of regularly-used standard(s) is analysed. The precision of retention 
time(s) can be measured by injecting the standard three times or more. Peak areas 
can also be measured (see below under integrators). It is useful to plot parameters 
such as retention times/indices on a control chart.
Verification interval: Monthly.
Parameters to be verified: Detector sensitivity, baseline signal and background noise.
Method: A set of regularly-used standard(s) is analysed and compared with previ-
ous runs.
Verification interval: Monthly.Calibration/performance verification of instruments and equipment  45
Parameters to be calibrated: Flow rates of detector gases.
Method: A bubble flow meter or calibrated electronic flow meter is used according 
to the manufacturer’s instructions. 
Calibration interval: When detector is cleaned or serviced, or the analytical column 
is  changed,  or  when  performance  has  deteriorated.  Difficulty  in  lighting  a  flame 
ionization detector often indicates that the flow rates are incorrect.
High performance liquid chromatographs
Routine maintenance of HPLC systems includes regular changing of inlet and in-line 
filters  and  guard  columns,  which  are  usually  changed  when  the  back-pressure 
increases beyond acceptable limits (i.e. above the maximum column pressure). If 
methods are transferred between different instruments, it may be necessary to check 
the accuracy of some parameters such as flow rate, column temperature and gradient 
composition, which will affect retention times and relative retention times.
Parameter to be calibrated: Flow accuracy.
Method:  The  column  effluent  is  collected  in  a  measuring  cylinder  or  volumetric 
flask over an appropriate interval.
Calibration interval: The absolute flow rate is often less important than its variation 
during  a  set  of  analyses,  but  it  should  be  checked  if  a  standardized,  official  or 
recommended method is being implemented.
Parameters to be calibrated: Flow repeatability and precision of injector volume.
Method: A set of regularly-used standards is injected three times or more and the 
precision of retention times and peak areas is measured.
Calibration interval: Monthly, or this test may form part of a daily system suitability 
test.
Parameter to be calibrated: Detector signal: noise ratio.
Method: A set of regularly used standards is analysed and compared with previous 
runs. Baseline noise is measured in intervals of 0.5-1 minute and the average is 
calculated. The noise is calculated using a computer programme (if supplied by 
the manufacturer) or graphically, by drawing two horizontal lines which enclose 
all observed variations and measuring the vertical distance between them. The noise 
level can be measured with and without solvent flow, to establish the contribution 
made by the solvent delivery system.
Calibration interval: Monthly.46  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
Parameter  to  be  calibrated: Accuracy  of  detector  wavelength(s)  (UV-visible  and 
fluorescence detectors).
Method: UV absorption wavelengths are checked with a holmium oxide filter, sup-
plied by the manufacturer, (and traceable to a primary standard) which has a char-
acteristic absorption wavelength maximum at 361 nm. The wavelength accuracy and 
reproducibility are checked over the entire UV-visible range. The maximum (allow-
able) deviation is ±1.0 nm. Fluorescence emission wavelengths are usually checked 
using a standard, for example, quinine sulphate which has excitation peaks at 255 
and 355 nm and emission peak at 455 nm.
Calibration interval: Annually.
Mass spectrometers
Mass spectrometers are tuned and calibrated in a similar manner whether they are 
stand-alone instruments or combined with chromatographic interfaces (GC-MS and 
LC-MS  and  their  multi-sector  derivations).  Differences  arise  between  quadrupole 
and magnetic sector instruments, especially if the latter are capable of high resolu-
tion. Most bench-top instruments are controlled directly by a computer data system, 
and tuning and calibration are carried out automatically. Warnings are generated by 
the data system if the instrument fails to achieve the pre-set performance character-
istics, often mandating operator intervention, for example to clean the source. 
Parameters to be calibrated: Source tuning and mass calibration.
Method: A calibration compound such as perfluorokerosene (PFK) or heptacosafluoro-
tributylamine  (perfluorotributylamine)  is  introduced  to  the  spectrometer  using  a 
direct inlet device. The source is tuned using selected fragment ions to give optimum 
sensitivity and peak shape, and obtain peak ratios (for example, of m/z 69, 219 and 
264  and  502  in  the  perfluorotributylamine  spectrum)  usually  determined  by  the 
manufacturer. Spectra are recorded and compared with the reference spectrum with 
respect to mass assignments and relative peak intensities.
Calibration interval: Daily or immediately prior to use
Chromatographic integrators and data systems
The validation of computer systems and software is a particularly important exercise 
which should be carried out by the manufacturer. However, it remains the respon-
sibility of the user to ensure that the software has been validated Formal validation 
of software can be carried out by the supplier on behalf of the user, but the user 
should carry out a formal acceptance test based on acceptance criteria for software. Calibration/performance verification of instruments and equipment  47
Manufacturers now routinely include test and diagnostic functions in their products 
for system validation.
Parameter to be calibrated: Accuracy of integrated peak areas.
Method:  Either  an  in-built  test  function  in  the  chromatograph  is  used  or  else  a 
routinely-run standard is used, and compared with previous runs.
Calibration interval: Routine standards are usually run on a daily basis. Tests of 
hardware function can be carried out at longer intervals, for example monthly.49
4.    Model standard operating 
procedure for validation of  
a new analytical method
A  clearly  written  standard  operating  procedure  (SOP)  is  required  to  perform  the 
validation of a method. Several examples of SOP’s for chromatographic methods 
have been published [19]. The following model is not universally applicable since 
it  is  not  possible  to  create  a  single  protocol  or  SOP  to  cover  all  situations. The 
guidelines given here are for the most commonly encountered situations.
Laboratory name Revision  Page
  1/x
Author  Reviewer Acceptor Previous revision Date
File Code 
Title of the SOP
e.g. Validation of a Gas Chromatographic Methods
Purpose of the SOP
This section should contain be a brief instruction of the method to be validated, 
including planning, performance and documentation.
Performance of validation
Insert detailed instructions of the work to be carried out to determine the validation 
parameters.50  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
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Calculation of results and interpretation
Describe  the  procedures  how  to  calculate  the  parameters  using  the  experimental 
results and acceptance criteria—see part 2.9. of this manual.
Reporting the results
Report  the  results  of  validation. The  method  should  be  described,  the  results  for 
each validation parameter should be documented and conclusions should be drawn 
as to whether the method is fit for purpose.
Archiving the validation study data
The validation report (signed, dated and authorized) should be retained along with 
the validation plan and all the experimental validation data under secure storage 
and be readily retrievable.
References
These are the ones referred to in this SOP e.g. references describing the theory of 
validation.53
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Annex.    A glossary of terms used  
in the validation and 
calibration manual
Definitions are taken from the UNODC Glossary (ST/NAR/26) plus additional terms 
or  additional  definitions  (marked  with  an  asterisk).  References  to  the  sources  of 
definitions can be found in ST/NAR/26, if not given below.
Acceptance criteria: Conditions which must be fulfilled before an operation, process 
or item, such as a piece of equipment, is considered to be satisfactory or to have 
been completed in a satisfactory way. Specific examples are given below.
Acceptance criteria (for software):* The criteria a software product must meet 
to complete successfully a test phase or to achieve delivery requirements.
Acceptance criteria for specimens: Procedures for acceptance or rejection 
of  specimens  arriving  at  the  analytical  laboratory.  Such  procedures  are 
focused on assessing the adequacy of chain of custody.
Accuracy (bias, trueness): Ability to get the true result [1]. For quantitative tests 
the accuracy expresses the closeness of agreement between the true value and the 
value obtained by applying the test procedure a number of times. It is affected by 
systematic and random errors.
Accuracy (of a measuring instrument):   
“Ability of a measuring instrument to give responses close to a true value.”  
Note: In this context accuracy is a qualitative concept [2].
Analyte (or target analyte): Substance to be identified or measured. 
Surrogate analyte: A well-characterized substance which is taken as rep-
resentative of the analyte [3].
Analytical run or batch:* A complete set of analytical samples with appropriate 
number of standards and quality control samples for their validation. Several runs 
(or batches) may be completed in one day, or one run (or batch) may take several 
days to complete. 56  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
Analytical system (measurement system):* A complete set of measuring instru-
ments and other equipment assembled to carry out a specified measurement task 
[4]. In the context of analysing controlled drugs in seized materials or biological 
specimens,  the  analytical  system  consists  of  the  laboratory  balance(s),  pH  meter, 
chromatograph, thin layer chromatography equipment etc. which are used by the 
analyst to carry out the analysis.
Arithmetic mean or average: Sum of the individual values in a set divided by the 
number of values.
Average: See arithmetic mean.
Batch (or analytical batch): A group of one or more samples that are analysed 
under conditions approaching repeatability. Usually it should contain calibrators and 
quality control samples in addition to the real samples to be analysed.
Biological matrix:* A discrete material of biological origin that can be sampled 
and processed in a reproducible manner. Examples are blood, serum, plasma, urine, 
faeces, saliva, sputum, and various discrete tissues
Blank: Specimen not containing the analyte.
Calibration: The set of operations which establish, under specified conditions, the 
relationship between values indicated by a measuring instrument or measuring sys-
tem,  or  values  represented  by  a  material  measure,  and  the  corresponding  known 
values of a measurand 
Calibration curve: The relationship between the signal response of the instrument 
and various concentrations of analyte in a suitable solvent or matrix.
Calibration interval:* The frequency of specific performance tests that are made 
on  each  instrument  or  item  of  equipment  as  part  of  the  laboratory’s  preventive 
maintenance programme.
Calibration range:* See range.
Calibration standard:* a biological matrix to which a known amount of analyte 
has been added or spiked. Calibration standards are used to construct calibration 
curves from which the concentrations of analytes in quality control and unknown 
samples are determined.
Calibrator: Pure analyte in a suitable solvent or matrix used to prepare the cali-
bration curve. Calibrators are similar in composition to controls but must be pre-
pared separately from them, since controls are used to check on the accuracy of 
the   calibration curve.Annex  57
Candidate method:* An analytical method which has been selected and developed 
for a particular analytical problem and which must be validated to show that it is 
fit for the intended analytical purpose before being used.
Certification: Procedure by which a certifying body gives formal recognition that 
the body, person or product complies with given specifications.
Certified reference material (CRM): A reference material one or more of whose 
property values are certified by a technical procedure, accompanied by or traceable 
to a certificate or other documentation which is issued by a certifying body. 
Certifying body: Independent science-based organization which has the competence 
to grant certifications. The certifying body may or may not be accredited.
Co-chromatography:* This is a procedure in which the purified test solution prior 
to the chromatographic step(s) is divided into two parts and:
- one part is chromatographed as such;
-   the standard analyte that is to be identified is added to the other part and 
this  mixed  solution  of  test  solution  and  standard  analyte  is  chromato-
graphed. The amount of standard analyte has to be similar to the estimated 
amount of the analyte in the test solution [5].
Coefficient  of  variation  (or  relative  standard  deviation):  A  measure  used  to 
compare the dispersion or variation in groups of measurements. It is the ratio 
of the standard deviation to the mean, multiplied by 100 to convert it to a per-
centage of the average.
Collaborative  studies  or  interlaboratory  test  comparisons:  Organization,  per-
formance and evaluation of tests on the same or similar items or materials by two 
or more different laboratories in accordance with predetermined conditions. The main 
purpose is validation of analytical methods or establishment of reference methods.
Concentration: Amount of a substance, expressed in mass or molar units, in a unit 
volume of fluid or mass of solid.
Confidence level (or confidence coefficient): The measure of probability associated 
with a confidence interval expressing the probability of the truth of a statement that 
the interval will include the parameter value.
Confidence interval: A range of values which contains the true value at a given 
level of probability. This level of probability is called the confidence level.
Contamination:* Gain of analyte during the extraction process, in contrast to the 
losses usually incurred which are assessed by the recovery. 58  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
Control chart: Graphical plot of test results with respect to time or sequence of 
measurements, with limits drawn within which results are expected to lie when the 
analytical scheme is in a state of statistical control [6].
Controls: Specimens used to determine the validity of the calibration curve, that 
is, the linearity and stability over time of a quantitative test or determination. Con-
trols are either prepared from the reference material (separately from the calibrators, 
that  is,  weighed  or  measured  separately),  purchased,  or  obtained  from  a  pool  of 
previously analysed specimens. Where possible, controls should be matrix-matched 
to specimens and calibrators.
Correction for recovery:* The recovery of analytes in a method is frequently less 
than 100%. If there is no internal standard (which automatically compensates for 
incomplete recovery) then the results of analysis must be multiplied by a correction 
factor to obtain the values which would have been produced if the recovery had 
been 100%. This implies that the recovery of the method is known, which will be 
true if the method has been validated, as recovery is one of the performance char-
acteristics which is measured. 
Correlation coefficient: A number showing the degree to which two variables are 
related. Correlation coefficients range from 0 (no correlation) to –1 or +1 (perfect 
correlation).
Cut-off concentration (or threshold): The concentration of a drug in a specimen 
used to determine whether the specimen is considered positive or negative. In some 
circumstances it is recommended that the cut-off concentration should be set equal 
to the limit of detection. See also threshold.
End determination (end-step determination):* The final step in a sequence of 
stages  comprising  an  analytical  method,  usually  involving  the  application  of  a 
technique to an extract or other sample preparation to produce data on the com-
position of the sample. 
Equipment:* In general, the apparatus required for any operation [7]. More specifi-
cally, the analytical measurement hardware, for example a gas chromatograph. 
Error: Something done which is considered to be incorrect or wrong.
Random error: A component of the total error of a measurement which 
varies in an unpredictable way. This causes the individual results to fall on 
both sides of the average value.
Systematic error: A component of the total error of a measurement which 
varies in a constant way. This causes all the results to be in error in the 
same sense.
Total error: The sum of random and systematic errors.Annex  59
External standard:* One prepared directly from a reference substance, for example 
as a stock solution or serial dilutions of the stock solution. It is not prepared in the 
same type of matrix as the specimens or samples for analysis and therefore there 
is no requirement for an extraction step prior to analysis.
False negative: A test result which states that no drug is present when, in fact, a 
tested  drug  or  metabolite  is  present  in  an  amount  greater  than  a  threshold  or  a 
designated cut-off value
Goodness of fit: How well a model, a theoretical distribution, or an equation matches 
actual data. 
Instrument  (instrumentation,  measuring  instrument):*  A  device  intended  to 
make a measurement, alone or in conjunction with other equipment. 
Interference study:* A study to check the selectivity (or specificity) of a method 
by adding materials which might be encountered in specimens and which it is sus-
pected might cause interference.
Interlaboratory studies (or interlaboratory tests comparisons): See collaborative 
studies.
Internal standard: The addition of a fixed amount of a known substance which is 
not already present as a constituent of the specimen in order to identify or quantify 
other  components.  The  physico-chemical  characteristics  of  the  internal  standard 
should be as close as possible those of the analyte. Test compound(s) (e.g. structur-
ally similar analog, stable labelled compound) added to both calibration standards 
and samples at known and constant concentration to facilitate quantification of the 
target analyte(s).
International standard:* A standard recognized by an international agreement to 
serve internationally as the basis for fixing the value of all other standards of the 
quantity concerned.
Laboratory: Facilities where analyses are performed by qualified personal and with 
adequate equipment.
Laboratory manager:* The qualified individual who assumes professional, organi-
zational,  educational  and  administrative  responsibility  for  the  laboratory’s  drug 
testing.
Limit of detection (LOD): The smallest measured content from which it is possible 
to deduce the presence of the analyte with reasonable statistical certainty. The lowest 
concentration of an analyte that the analytical procedure can reliably differentiate 
from background noise. The lowest content that can be measured with reasonable 
statistical certainty60  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
Limit of quantitation (LOQ)/lower limit of quantification (LLOQ): The smallest 
measured content from which it is possible to quantify the analyte with an acceptable 
level of accuracy and precision. In some laboratories the LLOQ is termed the lowest 
calibration concentration of the working range, as accuracy and precision of this 
concentration is verified in every analytical run/batch. The content equal to greater 
than the lowest concentration point on the calibration curve.
Linear regression: A method of describing the relationship between two or more 
variables by calculating a “best fitting” straight line or graph.
Linearity:* The linearity of an analytical method is its ability to elicit test results 
that are directly, or by means of well-defined mathematical transformations, propor-
tional to the concentration of analytes in samples within a given range. (See also 
linear regression). Linearity defines the ability of the method to obtain test results 
proportional to the concentration of the analyte.
Matrix: Material that contains the analyte, e.g. urine or blood.
Matrix effect:* The direct or indirect alteration or interference in response of an 
instrument  such  as  LC-MS/MS  due  to  the  presence  of  unintended  analytes  (for 
analysis) or other interfering substances in the samples.
Mean: When not otherwise specified, refers to arithmetic mean.
Measurement:* The set of operations having the object of determining a value of 
a quantity.
Measurement system:* See analytical system.
Measuring instrument:* See instrument.
Method (or analytical method): Detailed (defined) procedure of a technical opera-
tion for performing an analysis.
Method authorization form:* A document which certifies that an analytical method 
has been validated for its intended purpose in the laboratory and has been authorized 
for that purpose by the laboratory manager, who should sign the form.
Method validation:* Confirmation by examination and provision of objective evi-
dence that the particular requirements for a specific intended use of a method are 
fulfilled  [8].  The  United  States  Pharmacopoeia  defines  validation  of  an  analytical 
method  as  the  process  by  which  it  is  established,  by  laboratory  studies,  that  the 
performance  characteristics  of  the  method  meet  the  requirements  for  the  intended 
  analytical application. A working definition may include the ideas that a valid method.
- is suitable (reliable) for its purpose;
- provides useful analytical data in a specific situation;Annex  61
- meets the pre-determined requirements (specifications) of the analytical problem;
- has an established level of performance (accuracy, consistency, reliability);
- does what it is supposed to do.
National standard:* A standard recognized by an official national decision as the basis 
for fixing the value, in a country, of all other standards of the quantity concerned. 
Negative: Indicates that the analyte is absent or below a designated cut-off concen-
tration. “Not detected” is sometimes used as a synonym of negative although this 
is not recommended.
Organization: Companies, corporations or institutes (or part of one, e.g. laboratory) 
private or public, that has its own functions and administration. Some of the inter-
national organizations dealing with quality assurance are: ISO, IUPAC, IOC, TIAFT, 
IFCC, IPCS, OECD.
Performance characteristics:* These are key aspects of an analytical method which 
are  evaluated  for  the  purposes  of  method  development  and  validation,  including 
accuracy (bias), linearity, limit of detection, limit of quantitation, range, recovery, 
repeatability, reproducibility, ruggedness, and specificity (selectivity). 
Performance qualification:* See performance verification.
Performance verification (or performance qualification):* A formal and nation-
ally traceable method of evaluating the performance of an instrument against previ-
ously defined procedures and specifications. Performance verification should involve 
the use of tests which are not method-specific and which use Nationally-traceable 
calibrators and standards
Positive: Indicates that the analyte is present at a level above a designated cut-of 
concentration.
Practicability:* The ability to put something into practice. In the laboratory, this 
means the absence of unnecessarily sophisticated equipment, reagents, instruments, 
or environmental conditions, so that a method is suitable for routine use [9].
Precision: The closeness of agreement (degree of scatter) between independent test 
results obtained under prescribed conditions. It is generally dependent on analyte 
concentration,  and  this  dependence  should  be  determined  and  documented.  The 
measure of precision is usually expressed in terms of imprecision and computed as 
a standard deviation of the test results. Higher imprecision is reflected by a larger 
standard deviation. Independent test results means results obtained in a manner not 
influenced by any previous results on the same or similar material. Precision covers 
repeatability and reproducibility.62  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
A measure for the reproducibility of measurements within a set, that is, of the scat-
ter or dispersion of a set about its central value.
Precision (intermediate):* Precision measured in-between repeatability and repro-
ducibility  conditions:  for  example  precision  measured  between  different  analysts, 
over  extended  timescales,  within  a  single  laboratory.  Expresses  within  laboratory 
variation: different days, different analysts, different equipment, etc.
Primary standard:* A standard which has the highest metrological qualities in a 
specified field. 
Probability: A mathematical measurement of how likely it is that something will 
happen, expressed as a fraction or percentage. Values for statistical probability range 
from 1 or 100% (always) to 0 or 0% (never). The relative frequency obtained after 
a long run of measurements or results will give good approximations to the true 
probabilities. Also, it is a basic concept which may be taken either as indefinable, 
expressing in some way a “degree of belief”, or as the limiting frequency of an 
occurrence in an infinite random series.
Procedure: A specified way to perform an activity. For quality assurance purposes 
the procedures should be written. Specified way to carry out an activity or process.
Quality assurance: All the planned and systematic activities implemented within 
the  quality  system,  to  provide  adequate  confidence  that  a  laboratory  will  fulfil 
requirements for quality. Part of quality management focused on providing confi-
dence that quality requirements will be fulfilled.
Quality control: The overall system of laboratory procedures and processes which 
controls the quality of the laboratory’s analytical results.
Quality manual: A document stating the general quality policies, procedures and 
practices  of  an  organization  [10].  Document  specifying  the  quality  management 
system of an organization.
Quantitation (quantification) range:* The range of concentrations, including ULOQ 
and LLOQ, that can reliably and reproducibly quantified with accuracy and precision 
through the use of a concentration-response relationship (see also range).
Random error: See error.
Range  (working  range,  calibration  range):  Concentration  interval  for  which 
acceptable accuracy and precision can be achieved. Statistically it is the difference 
between the minimum and the maximum values of a set of measurements.
Recovery: The percentage of the drug, metabolite, or internal standard originally 
in the specimen that reaches the end of the procedure. Annex  63
Term used in analytical and preparative chemistry to denote the fraction of the total 
quantity of a substance recoverable following a chemical procedure. It is measured 
by adding a known amount of analyte to a blank matrix and comparing this with 
the amount measured as present by analysis.
Reference method: One which is developed by organizations or groups that use 
collaborative studies or similar approaches to validate them. Its value depends on 
the authority of the organizations which sponsor it.
Reference  standard: A  standard,  generally  of  the  highest  quality  available  at  a 
given location, from which measurements made at that location are derived.
Reliability: The extent to which an experiment, test, or measuring procedure yields 
accurate results on repeated trials.
Repeatability (or repeatable): The closeness of the agreement between the results 
of successive measurements of the same analyte made under repeatable conditions, 
e.g.  same  method,  same  material,  same  operator,  same  laboratory,  narrow  time 
period. Results should be expressed in terms of the repeatability standard deviation, 
repeatability coefficient of variation, or the confidence interval of the mean value. 
Closeness of the agreement between the results of successive measurements of the 
same measurand carried out under the same conditions of measurement.
Replicability:* See replicate analysis.
Replicate  analysis: The  multiple  analysis  of  separate  portions  of  a  test  material 
using  the  same  test  method  under  the  same  conditions  e.g.  same  operator,  same 
equipment, same laboratory.
Reproducibility (within laboratory): The closeness of the agreement between the 
results of successive measurements of the same analyte in identical material made 
by  the  same  method  under  different  conditions,  e.g.  different  operators,  different 
laboratories, long time period. Results should be expressed in terms of the reprodu-
cibility standard deviation; reproducibility coefficient of variation, or the confidence 
interval of the mean value. It also represents precision of the method under the same 
operating conditions over a short period of time. Closeness of the agreement between 
the  results  of  measurements  of  the  same  measurand  carried  out  under  changed 
conditions of measurement.
Robustness:* The ability of a method to remain unaffected by small but deliberate 
variations in the main parameters of the method. The robustness of an analytical 
procedure is a measure of its capacity to remain unaffected by small but deliberate 
variations in method parameters and provides an indication of its reliability during 
normal usage.
Ruggedness:* The ability of a measurement process to withstand small uncontrolled 
or unintentional changes in its operating conditions. The ruggedness of an analytical 64  Guidance for Testing of Illicit Drugs in Seized Materials and Biological Specimens
method is the degree of reproducibility of test results obtained by the analysis of 
the same samples under a variety of conditions, such as different laboratories, ana-
lysts, instruments, lots of reagents, elapsed assay times, assay temperatures or days. 
Ruggedness  is  normally  expressed  as  the  lack  of  influence  on  the  test  results  of 
operational and environmental variables of the analytical method. Ruggedness is a 
measure of reproducibility of test results under the variation in conditions normally 
expected from laboratory to laboratory and from analyst to analyst.
Ruggedness test:* An intralaboratory experimental plan, used before undertaking 
an interlaboratory study, to examine the behaviour of an analytical process when 
small changes in the environmental and/or operating conditions are made, akin to 
those likely to arise in different laboratories. 
Selectivity (or specificity): Refers to the extent to which a method can determine 
particular analyte(s) in a complex mixture without interference from the other com-
ponents  in  the  mixture. A  method  which  is  perfectly  selective  for  an  analyte  or 
group of analytes is said to be specific. The term specific (in analysis) is considered 
as the ultimate of selectivity. 
Qualitative: The extent to which other substances interfere with the determination 
of a substance according to a given procedure; quantitative: a term use din conjunc-
tion with another substantive (e.g. constant coefficient, index, factor, number) for 
the quantitative characterization of interferences.
Sensitivity: (a)  The difference in analyte concentration corresponding to the small-
est difference in the response of the method that can be detected. It is represented 
by the slope of the calibration curve. It is also equivalent to three time the average 
background reading produced by blank samples from as many different sources as 
possible (5 minimum, but 20 different sources are ideal). Sometimes sensitivity is 
erroneously used instead of limit of detection. 
    (b)  The incidence of true positive results obtained when a test is applied to 
samples known to contain the analyte [11]. 
    (c)  The change in the response of a measuring instrument divided by the 
  corresponding change in the stimulus
Specification: Statement of requirements, usually in written form.
Specificity: (a) See selectivity. 
    (b)  Incidence of true negative results obtained when a test is applied to sam-
ples known not to contain the analyte. 
    (c)  The  ability  of  a  method  to  measure  only  what  is  applied  to  samples. 
“Specificity  is  the  ability  to  assess  unequivocally  the  analyte  in  the  presence  of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix etc.”Annex  65
Specimen: Any material for examination, study or analysis.
Spiked sample: A test material containing a known addition of analyte.
Stability (of sample during the analysis): Resistance to decomposition or other 
chemical changes, or to physical disintegration.
Standard analyte:* A well-defined substance in its highest available purity to be 
used as a reference in the analysis.
Standard deviation: A statistic that shows the spread or dispersion of results in a 
distribution of results. It is calculated by taking the square root of the variance. It 
is applicable to all kinds of repeated measurements, e.g. between batch, within batch, 
repeatability, reproducibility, etc. 
Standard operating procedure (SOP): Written procedures which describe how to 
perform certain laboratory activities.
System suitability test:* Validation of an analytical system (system suitability test-
ing)  tests  a  system  against  documented  performance  specifications,  for  a  specific 
analytical method [12].
Systematic error: See error.
Technique:* A technique is a scientific principle, for example gas chromatography 
or ultraviolet spectrometry, that can be used to provide data on the composition of 
a material. It is unusual to apply a technique directly to a test sample, as extraction 
and other steps are frequently required. A technique is therefore used in the last 
step  of  an  analytical  method  which  is  usually  the  end-determination  or  end-step 
determination.
Test: A technical operation to determine one or more characteristics of or to evalu-
ate  the  performance  of  a  given  product,  material,  equipment,  organism,  physical 
phenomenon, process or service according to a specified procedure.
Theoretical probability distribution: The number of times it can be expected to 
get a particular number of successes in a large number of trials. Important theoreti-
cal probability distributions are the normal, t-, chi-square and F-distributions.
Threshold: A  particular,  significant  amount,  level,  or  limit,  at  which  something 
begins to happen or take effect. See also Cut-off concentration.
Traceable: See traceability.
Traceable standard:* A reference standard which also has the property of traceabil-
ity.  It  will  usually  have  a  certificate  of  analysis  giving  details  of  the  national  or 
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Traceability: The ability to trace the history, application or location of an entity by 
means of recorded identification. The property of a result of a measurement whereby 
it can be related to appropriate standards, generally international or national stand-
ards, through an unbroken chain of comparisons. Property of the result of a meas-
urement or the value of a standard whereby it can be related with a stated uncertainty, 
to  stated  references,  usually  national  or  international  standards  (i.e.  through  an 
unbroken chain of comparisons. Ability to trace the history, application or location 
of that which is under consideration.
True value: See value.
Uncertainty: A parameter, associated with the result of a measurement, that char-
acterises  the  dispersion  of  the  values  that  could  reasonably  be  attributed  to  the 
analyte. An estimate attached to a test result which characterizes the range of values 
within which the true value is asserted to lie.
Upper  limit  of  quantification  (ULOQ):  the  highest  amount  of  an  analyte  in  a 
sample that can be quantitatively determined with precision and accuracy.
Validation: Confirmation by examination and provision of objective evidence that 
the particular requirements for a specific intended use are fulfilled. See also method 
validation.
Value: The expression of a quantity in terms of a number and an appropriate unit 
of measurement.
True value: The value which characterizes a quantity perfectly defined in the condi-
tions which exist when that quantity is considered. The true value of a quantity is 
an ideal concept and, in general, cannot be known exactly. Value consistent with 
the definition of a given particular quantity.
Verification: Confirmation by examination and provision of objective evidence that 
specified requirements have been fulfilled. Confirmation, through the provision of 
objective evidence, that specified requirements have been fulfilled.
Working range:* See range.67
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